Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 1
Treatment-assignment count: 0
Stratification count: 0
Cdx Established Context
MSI-H / dMMR
melanoma · Immune Checkpoint Inhibitor
MSI-H / dMMR is flagged as cdx established context because public trials show inclusion required evidence in 2 contexts. FDA CDx context exists.
Threshold snippets
Fragmentation view
Threshold count: 4
Common snippets: MSI-H | MSI-H | MSI-H
Threshold label: Moderate
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Exists
CDx maturity score: 5/5
Confidence: Medium
Patent-density signal
Diagnostic appendix
Signal count: 0
Recent signals: 0
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT02332668 | https://clinicaltrials.gov/study/NCT06034860